Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Beckhove

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Beitrage Zur Pathologie|January 1, 1971
[Post-mortem DNA changes in heart muscle]C P Adler, P Beckhove
Cancer Immunology, Immunotherapy : CII|February 14, 2008
Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007V Schirrmacher, P Beckhove, P Fournier, et al.
British Journal of Haematology|November 5, 1997
Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm typeO Meyer, D Stahl, P Beckhove, et al.
International Journal of Oncology|January 15, 2002
Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cellsL Bai, M Feuerer, P Beckhove, et al.
Immunology|February 1, 1996
A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivoV Umansky, P Beckhove, M Rocha, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 1994
Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protectionK Khazaie, S Prifti, P Beckhove, et al.
Clinical and Experimental Immunology|February 4, 2015
Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancerT Schneider, A Sevko, C P Heussel, et al.
International Journal of Oncology|May 11, 2011
Effective immune rejection of advanced metastasized cancerV Schirrmacher, P Beckhove, A Kruger, et al.
Nature Medicine|April 3, 2001
Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrowM Feuerer, P Beckhove, L Bai, et al.
Oncogene|October 24, 2007
The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodiesD Gast, S Riedle, Y Issa, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Beitrage Zur Pathologie|January 1, 1971
[Post-mortem DNA changes in heart muscle]C P Adler, P Beckhove
Cancer Immunology, Immunotherapy : CII|February 14, 2008
Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007V Schirrmacher, P Beckhove, P Fournier, et al.
British Journal of Haematology|November 5, 1997
Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm typeO Meyer, D Stahl, P Beckhove, et al.
International Journal of Oncology|January 15, 2002
Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cellsL Bai, M Feuerer, P Beckhove, et al.
Immunology|February 1, 1996
A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivoV Umansky, P Beckhove, M Rocha, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 1994
Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protectionK Khazaie, S Prifti, P Beckhove, et al.
Clinical and Experimental Immunology|February 4, 2015
Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancerT Schneider, A Sevko, C P Heussel, et al.
International Journal of Oncology|May 11, 2011
Effective immune rejection of advanced metastasized cancerV Schirrmacher, P Beckhove, A Kruger, et al.
Nature Medicine|April 3, 2001
Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrowM Feuerer, P Beckhove, L Bai, et al.
Oncogene|October 24, 2007
The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodiesD Gast, S Riedle, Y Issa, et al.
Pageof 2